Selected research publications
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies – Journal: Vaccine – Published: 7th March 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial – Journal: The Lancet Microbe – Published: 13th February 2026
13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults – Journal: Vaccine – Published: 22nd January 2026
Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate Streptococcus pneumoniae serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18–50 years in the UK (RATIONALE-15) – Journal: BMJ Open – Published: 24th November 2025
The effect of Pneumococcal Conjugate Vaccine and Pneumococcal Polysaccharide Vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B: a randomised controlled trial – Journal: The Lancet Microbe – Published: 29th September 2025
View more publications